Current Pharmacogenomics and Personalized Medicine
Title: Editorial [Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA)]
Volume: 9 Issue: 4
Author(s): Yann Joly, Richard G.H. Cotton, Eugene Kolker, Samer A. Faraj, Adam S. Ptolemy, Emmanuelle Vaast, Leela John, Yasemin Yazan, Candan Hizel, Ma'n H. Zawati, Vural Ozdemir, Edward S. Dove, Aresha Manamperi, Panga Jaipal Reddy, Ramy K. Aziz, Ghazi O. Tadmouri, Sanjeeva Srivastava, Louise Warnich and David S. Rosenblatt
Affiliation:
Keywords: Anticipatory ethics, Data-Enabled Life Sciences Alliance, DELSA, genomics without borders, global ethics and international development in pharmacogenomics, Human Variome Project, RaDiCAL, Rare Disease Consortium for Autosomal Loci
Export Options
About this article
Cite this article as:
Joly Yann, G.H. Cotton Richard, Kolker Eugene, A. Faraj Samer, S. Ptolemy Adam, Vaast Emmanuelle, John Leela, Yazan Yasemin, Hizel Candan, H. Zawati Ma'n, Ozdemir Vural, S. Dove Edward, Manamperi Aresha, Jaipal Reddy Panga, K. Aziz Ramy, O. Tadmouri Ghazi, Srivastava Sanjeeva, Warnich Louise and S. Rosenblatt David, Editorial [Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA)], Current Pharmacogenomics and Personalized Medicine 2011; 9 (4) . https://dx.doi.org/10.2174/187569211798377153
DOI https://dx.doi.org/10.2174/187569211798377153 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Epidemiology of Type 1 Diabetes in Latin America
Current Diabetes Reviews Atherosclerotic Plaque Stabilization - Potential Role for Immunomodulatory Therapy
Vascular Disease Prevention (Discontinued) Lipodystrophy, Insulin Resistance, and Adiponectin Concentration in HIV-Infected Children and Adolescents
Current HIV Research C-Reactive Protein and Atherosclerosis: An Update
Vascular Disease Prevention (Discontinued) Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
Current Neuropharmacology Fragment Pharmacophore-Based Screening: An Efficient Approach for Discovery of New Inhibitors of Toll-Like Receptor 5
Combinatorial Chemistry & High Throughput Screening Radiopharmaceutical: Revolutionary Agents for Diagnosis
Current Radiopharmaceuticals Hormonal, Metabolic and Hemodynamic Adaptations to Glycosuria in Type 2 Diabetes Patients Treated with Sodium-Glucose Co-Transporter Inhibitors
Current Diabetes Reviews Advanced Glycation: A Novel Outlook on Atherosclerosis
Current Pharmaceutical Design Developing a Vaccine Against Multiple Psychoactive Targets: A Case Study of Heroin
CNS & Neurological Disorders - Drug Targets Cutoff Values of D-Dimer and FDP in Plasma for the Diagnosis of Thrombosis
Vascular Disease Prevention (Discontinued) Synthesis and Biological Properties of Dihydro-Oxadiazine-Based Heterocyclic Derivatives
Mini-Reviews in Medicinal Chemistry Stem Cell-Derived Microvesicles: A Cell Free Therapy Approach to the Regenerative Medicine
Current Biotechnology Imidazoline Receptors, Novel Agents and Therapeutic Potential
Cardiovascular & Hematological Agents in Medicinal Chemistry Involvement of the AcrAB Efflux Pump in Ciprofloxacin Resistance in Clinical <i>Klebsiella Pneumoniae</i> Isolates
Infectious Disorders - Drug Targets Sudden Infant Death Syndrome: A Review of the Literature
Current Pediatric Reviews Nutrition in Allogeneic Stem Cell Transplantion - Clinical Guidelines and Immunobiological Aspects
Current Pharmaceutical Biotechnology Infection and Hemodialysis Access: An Updated Review.
Infectious Disorders - Drug Targets VIP as a Potential Therapeutic Agent in Gram Negative Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Chromium-Picolinate Therapy in Diabetes Care: Molecular and Subcellular Profiling Revealed a Necessity for Individual Outcome Prediction, Personalised Treatment Algorithms & New Guidelines
Infectious Disorders - Drug Targets